Literature DB >> 20837538

Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.

Agda Karina Lucio-Eterovic1, Melissa M Singh, Jeffrey E Gardner, Chendhore S Veerappan, Judd C Rice, Phillip B Carpenter.   

Abstract

The NSD (nuclear receptor-binding SET domain protein) family encodes methyltransferases that are important in multiple aspects of development and disease. Perturbations in NSD family members can lead to Sotos syndrome and Wolf-Hirschhorn syndrome as well as cancers such as acute myeloid leukemia. Previous studies have implicated NSD1 (KMT3B) in transcription and methylation of histone H3 at lysine 36 (H3-K36), but its molecular mechanism in these processes remains largely unknown. Here we describe an NSD1 regulatory network in human cells. We show that NSD1 binds near various promoter elements and regulates multiple genes that appear to have a concerted role in various processes, such as cell growth/cancer, keratin biology, and bone morphogenesis. In particular, we show that NSD1 binding is concentrated upstream of gene targets such as the bone morphogenetic protein 4 (BMP4) and zinc finger protein 36 C3H type-like 1 (ZFP36L1/TPP). NSD1 regulates the levels of the various forms of methylation at H3-K36 primarily, but not exclusively, within the promoter proximal region occupied by NSD1. At BMP4 we find that this reduces the levels of RNAP II recruited to the promoter, suggesting a role for NSD1-dependent methylation in initiation. Interestingly, we also observe that the RNAP II molecules that lie within BMP4 have inappropriate persistence of serine-5 phosphorylation and reduced levels of serine-2 phosphorylation within the C-terminal domain (CTD) of the large subunit of RNAP II. Our findings indicate that NSD1 regulates RNAP II recruitment to BMP4, and failure to do so leads to reduced gene expression and abrogated levels of H3K36Me and CTD phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837538      PMCID: PMC2947892          DOI: 10.1073/pnas.1002653107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.

Authors:  Qi Zhao; Otavia L Caballero; Samuel Levy; Brian J Stevenson; Christian Iseli; Sandro J de Souza; Pedro A Galante; Dana Busam; Margaret A Leversha; Kalyani Chadalavada; Yu-Hui Rogers; J Craig Venter; Andrew J G Simpson; Robert L Strausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

2.  Histone H3 lysine 36 dimethylation (H3K36me2) is sufficient to recruit the Rpd3s histone deacetylase complex and to repress spurious transcription.

Authors:  Bing Li; Jessica Jackson; Matthew D Simon; Brian Fleharty; Madelaine Gogol; Chris Seidel; Jerry L Workman; Ali Shilatifard
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

3.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.

Authors:  María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong Cheung; Nazneen Rahman; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

4.  Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.

Authors:  Tao Lu; Mark W Jackson; Benlian Wang; Maojing Yang; Mark R Chance; Masaru Miyagi; Andrei V Gudkov; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 5.  Progression through the RNA polymerase II CTD cycle.

Authors:  Stephen Buratowski
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

Review 6.  A clinical study of Sotos syndrome patients with review of the literature.

Authors:  George Leventopoulos; Sophia Kitsiou-Tzeli; Konstantinos Kritikos; Stavroula Psoni; Ariadni Mavrou; Emmanuel Kanavakis; Helen Fryssira
Journal:  Pediatr Neurol       Date:  2009-05       Impact factor: 3.372

7.  Biased chromatin signatures around polyadenylation sites and exons.

Authors:  Noah Spies; Cydney B Nielsen; Richard A Padgett; Christopher B Burge
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

8.  A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.

Authors:  Keisuke Nimura; Kiyoe Ura; Hidetaka Shiratori; Masato Ikawa; Masaru Okabe; Robert J Schwartz; Yasufumi Kaneda
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

9.  Differential chromatin marking of introns and expressed exons by H3K36me3.

Authors:  Paulina Kolasinska-Zwierz; Thomas Down; Isabel Latorre; Tao Liu; X Shirley Liu; Julie Ahringer
Journal:  Nat Genet       Date:  2009-02-01       Impact factor: 38.330

10.  The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate.

Authors:  Yan Li; Patrick Trojer; Chong-Feng Xu; Peggie Cheung; Alex Kuo; William J Drury; Qi Qiao; Thomas A Neubert; Rui-Ming Xu; Or Gozani; Danny Reinberg
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

View more
  60 in total

Review 1.  Understanding the language of Lys36 methylation at histone H3.

Authors:  Eric J Wagner; Phillip B Carpenter
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-23       Impact factor: 94.444

Review 2.  Histone methyltransferases: novel targets for tumor and developmental defects.

Authors:  Xin Yi; Xue-Jun Jiang; Xiao-Yan Li; Ding-Sheng Jiang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 3.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

4.  Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.

Authors:  Gang Yuan; Ben Ma; Wen Yuan; Zhuqiang Zhang; Ping Chen; Xiaojun Ding; Li Feng; Xiaohua Shen; She Chen; Guohong Li; Bing Zhu
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 5.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

6.  An open and shut case for the role of NSD proteins as oncogenes.

Authors:  Agda Karina Lucio-Eterovic; Phillip B Carpenter
Journal:  Transcription       Date:  2011-07

Review 7.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

8.  NRMT2 is an N-terminal monomethylase that primes for its homologue NRMT1.

Authors:  Janusz J Petkowski; Lindsay A Bonsignore; John G Tooley; Daniel W Wilkey; Michael L Merchant; Ian G Macara; Christine E Schaner Tooley
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

9.  Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment.

Authors:  Wei Ma; Jing Ma; Jie Xu; Chong Qiao; Adam Branscum; Andres Cardenas; Andre T Baron; Peter Schwartz; Nita J Maihle; Yingqun Huang
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

Review 10.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.